Comparison and analyses of therapeutic effects between metabolic management center (MMC) and conventional management modes.

Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-5233 (Electronic) Linking ISSN: 09405429 NLM ISO Abbreviation: Acta Diabetol Subsets: MEDLINE

Publication: Berlin : Springer Verlag
Original Publication: Berlin : Springer International, c1991-

Comprehensive Health Care*/methods ; Comprehensive Health Care*/organization & administration ; Comprehensive Health Care*/standards ; Self-Management*/economics ; Self-Management*/methods ; Self-Management*/psychology ; Standard of Care*/economics ; Standard of Care*/organization & administration ; Standard of Care*/standards; Diabetes Mellitus, Type 2/*economics ; Diabetes Mellitus, Type 2/*therapy; China/epidemiology ; Diabetes Mellitus, Type 2/epidemiology ; Diabetes Mellitus, Type 2/metabolism ; Female ; Health Care Costs ; Humans ; Male ; Middle Aged ; Patient Education as Topic/economics ; Patient Education as Topic/organization & administration ; Patient Education as Topic/standards ; Patient Satisfaction ; Program Evaluation ; Surveys and Questionnaires

Aims: The past 3 decades witnessed the rapid growth of diabetes in China. To better serve large numbers of patients, the Chinese Medical Doctor Association launched metabolic management center (MMC) program which is featured with a one-stop and comprehensive diabetes management mode in 2016. It is worth exploring whether MMC model is better than conventional models in management.
Methods: In this study, 228 patients with type 2 diabetes were recruited, and 193 patients completed the study. Therapeutic effects and health care costs were analyzed.
Results and Conclusions: Our results showed that decreases in HbA 1C and TG/HDL-C values were significantly greater in the MMC group than in the control group. The increase in HDL-C was significantly higher in the MMC group than in the control group. The percentage of patients whose HbA 1C lower than 7% was significantly higher in the MMC group. The results of the UKPDS model simulation showed that within 30 years, with the slight increases in treatment costs, the average life expectancy and total QALE of the MMC group are higher than those of the control group by 0.61 and 0.51 year, respectively. Further study showed that the drug intervention in the MMC group was significantly stronger. In addition, the questionnaires revealed that MMC group performed better in diabetes knowledge tests and have higher patient satisfaction rates of medical services. More patients in the MMC group adopted a more favorable diet strategy. These advantages enable MMC to achieve more short-term and long-term benefits in diabetes treatment than conventional mode.

KJ2019CX013 Natural Science Foundation of Tongzhou District

Keywords: Economics; MMC; Patient education; Type 2 diabetes

Date Created: 20200406 Date Completed: 20201002 Latest Revision: 20201002

20221213

10.1007/s00592-020-01518-4

32248347